Fondazione Michelangelo   Report issue

Foundation Phase 1 Phase 2 Phase 3
Founded: Milan Italy (1998)

Organization Overview

First Clinical Trial
2000
NCT01251107
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Fondazione Michelangelo